Sanofi-Aventis, Cegedim Dendrite join forces

Cegedim Dendrite inked a three-year agreement with Sanofi-Aventis to provide Mobile Intelligence CRM solution to over 20,000 users across 28 countries including the US, France and Japan.

Laurent Labrune, CEO of Cegedim Dendrite, said that his company has demonstrated the best capability to proactively support Sanofi-Aventis' business model evolution toward multichannel CRM, key account and KOL management, with the lowest investment.

Labrune added that the integration of Mobile Intelligence Solution with OneKey will enable Sanofi-Aventis to benefit from a unique database on a worldwide scale, gaining the company an optimized ROI on data management.

The solution has just been deployed for the managed markets group in the US, France and Spain will follow in the first quarter of 2010.

Cegedim Dendrite is a provider of customer relationship management solutions.

The company also provides sales, marketing and regulatory compliance solutions in more than 80 countries.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.